Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 3:47 pm Sale | 2024-12-31 | 13G | Entrada Therapeutics, Inc. TRDA | Roche Finance Ltd | 2,569,115 6.900% | -175,005 (-6.38%) | Filing History |
| 2024-02-14 4:12 pm Sale | 2023-12-31 | 13G | Entrada Therapeutics, Inc. TRDA | Roche Finance Ltd | 2,744,120 8.200% | -69,405 (-2.47%) | Filing History |
| 2023-11-07 5:16 pm Purchase | 2023-10-25 | 13G | Aligos Therapeutics, Inc. ALGS | Roche Finance Ltd | 441,038 15.350% | 317,344 (+256.56%) | Filing History |
| 2023-02-13 4:52 pm Sale | 2022-12-31 | 13G | Eloxx Pharmaceuticals, Inc. ELOX | Roche Finance Ltd | 1,893 0.100% | -123,080 (-98.49%) | Filing History |
| 2023-02-13 4:49 pm Unchanged | 2022-12-31 | 13G | Jasper Therapeutics, Inc. JSPR | Roche Finance Ltd | 462,461 4.200% | 0 (Unchanged) | Filing History |
| 2022-02-14 06:20 am Purchase | 2021-12-31 | 13G | Tempest Therapeutics, Inc. TPST | Roche Finance Ltd | 72,612 1.100% | 72,612 (New Position) | Filing History |
| 2022-02-14 06:19 am Sale | 2021-12-31 | 13G | Vaxcyte, Inc. PCVX | Roche Finance Ltd | 2,334,113 4.400% | -253,641 (-9.80%) | Filing History |
| 2022-02-14 06:19 am Purchase | 2021-12-31 | 13G | Entrada Therapeutics, Inc. TRDA | Roche Finance Ltd | 2,813,525 9.000% | 2,813,525 (New Position) | Filing History |
| 2022-02-14 06:18 am Sale | 2021-12-31 | 13G | Allakos Inc. ALLK | Roche Finance Ltd | 2,629,157 4.800% | -1,916,566 (-42.16%) | Filing History |
| 2022-02-14 06:18 am Purchase | 2021-12-31 | 13G | Eloxx Pharmaceuticals, Inc. ELOX | Roche Finance Ltd | 124,973 5.800% | 61,667 (+97.41%) | Filing History |
| 2021-10-04 08:54 am Purchase | 2021-09-24 | 13G | Jasper Therapeutics, Inc. JSPR | Roche Finance Ltd | 462,461 12.700% | 462,461 (New Position) | Filing History |
| 2021-06-14 4:01 pm Purchase | 2021-04-01 | 13G | Eloxx Pharmaceuticals, Inc. ELOX | Roche Finance Ltd | 63,307 5.300% | 63,307 (New Position) | Filing History |
| 2021-03-02 4:15 pm Sale | 2021-02-26 | 13G | Senseonics Holdings, Inc. SENS | Roche Finance Ltd | 17,523,209 4.700% | -10,822,066 (-38.18%) | Filing History |
| 2021-02-16 07:03 am Purchase | 2019-12-31 | 13G | Allakos Inc. ALLK | Roche Finance Ltd | 4,545,723 9.300% | 1,766,566 (+63.56%) | Filing History |
| 2021-02-16 07:03 am Purchase | 2020-12-31 | 13G | Aligos Therapeutics, Inc. ALGS | Roche Finance Ltd | 123,694 8.100% | 123,694 (New Position) | Filing History |
| 2021-02-16 07:02 am Purchase | 2020-12-31 | 13G | PANDION THERAPEUTICS INC PAND | Roche Finance Ltd | 3,086,084 10.500% | 3,086,084 (New Position) | Filing History |
| 2021-02-16 07:02 am Purchase | 2020-12-31 | 13G | Vaxcyte, Inc. PCVX | Roche Finance Ltd | 2,587,754 5.100% | 2,587,754 (New Position) | Filing History |
| 2021-02-16 07:02 am Unchanged | 2020-12-31 | 13G | Millendo Therapeutics, Inc. MLND | Roche Finance Ltd | 72,612 5.700% | 0 (Unchanged) | Filing History |
| 2021-02-16 07:01 am Purchase | 2020-12-31 | 13G | Allakos Inc. ALLK | Roche Finance Ltd | 2,779,157 5.300% | 2,779,157 (New Position) | Filing History |
| 2021-02-16 07:01 am Purchase | 2020-12-31 | 13G | Senseonics Holdings, Inc. SENS | Roche Finance Ltd | 28,345,275 11.500% | 28,345,275 (New Position) | Filing History |